Related Experiment Video
Updated: Jul 20, 2026

Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis
Published on: February 6, 2021
Intracameral antibiotic agents for endophthalmitis prophylaxis: a pharmacokinetic model
Peter E Libre1, Phyllis Della-Latta, Nai Xun Chin
1Columbia University, New York, New York, USA. plibre@optonline.net
Purpose:
To assess in vitro whether intracameral antibiotic agents are plausibly effective prophylaxis against Staphylococcus aureus endophthalmitis.
Setting:
University research laboratory.Staphylococcus aureus was cultured for 8 hours with vancomycin (50 microg/mL) or piperacillin/tazobactam (512/64 microg/mL). Without reducing the bacterial counts, the antibiotic concentration was halved every 2 hours to simulate the half-life of antibiotic agents in the anterior chamber. The number of colony forming units (CFU)/mL was measured at 0, 2, 4, 6, and 8 hours.
Results:
Vancomycin inhibited the growth of methicillin-resistant S aureus such that the CFU/mL was 1000 times higher in the control group after 8 hours. Piperacillin/tazobactam nearly eliminated 1 oxacillin-susceptible strain and reduced the CFU/mL of another strain 1000-fold.
Conclusions:
Intracameral vancomycin may inhibit the growth of S aureus in the anterior chamber after surgery. Inhibiting the growth could increase the chances that the eye's innate defenses would eliminate the bacterial contamination that could cause endophthalmitis.
Insights
Intracameral vancomycin shows promise in preventing Staphylococcus aureus endophthalmitis by inhibiting bacterial growth in the eye. This may enhance the eye's natural defenses post-surgery.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Pharmacology
Background:
- Endophthalmitis is a severe intraocular infection often caused by Staphylococcus aureus.
- Prophylaxis against post-operative endophthalmitis is crucial for patient outcomes.
Purpose of the Study:
- To evaluate the in vitro efficacy of intracameral antibiotics against Staphylococcus aureus.
- To determine the potential of vancomycin and piperacillin/tazobactam as prophylactic agents for endophthalmitis.
Main Methods:
- Staphylococcus aureus strains were incubated with vancomycin or piperacillin/tazobactam in vitro.
- Antibiotic concentrations were serially halved to mimic anterior chamber half-life.
- Bacterial viability was assessed by measuring colony-forming units (CFU)/mL over 8 hours.
Main Results:
- Vancomycin significantly inhibited methicillin-resistant S. aureus growth, resulting in 1000-fold higher CFU/mL in controls after 8 hours.
- Piperacillin/tazobactam demonstrated potent activity, nearly eliminating one strain and reducing another's CFU/mL by 1000-fold.
Conclusions:
- Intracameral vancomycin exhibits inhibitory effects on Staphylococcus aureus in simulated anterior chamber conditions.
- These findings suggest intracameral vancomycin could be a viable prophylactic strategy against S. aureus endophthalmitis, potentially aiding the eye's immune response.
Related Concept Videos
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Pharmacodynamic Models: Overview
Pharmacodynamic Models: Linear Concentration–Effect Model
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Ophthalmic Drug Delivery Systems

